51 related articles for article (PubMed ID: 14719048)
1. Studies on Prostaglandin-Endoperoxide Synthase 1: Lower Levels in Schizophrenia and After Treatment with Antipsychotic Drugs in Conjunction with Aspirin.
Dean B; Gibbons A; Gogos A; Udawela M; Thomas E; Scarr E
Int J Neuropsychopharmacol; 2018 Mar; 21(3):216-225. PubMed ID: 30052978
[TBL] [Abstract][Full Text] [Related]
2. Antipsychotic-induced epigenomic reorganization in frontal cortex of individuals with schizophrenia.
Zhu B; Ainsworth RI; Wang Z; Liu Z; Sierra S; Deng C; Callado LF; Meana JJ; Wang W; Lu C; González-Maeso J
Elife; 2024 Apr; 12():. PubMed ID: 38648100
[TBL] [Abstract][Full Text] [Related]
3. Working memory processing deficit associated with a nonlinear response pattern of the anterior cingulate cortex in first-episode and drug-naïve schizophrenia.
Feng N; Palaniyappan L; Robbins TW; Cao L; Fang S; Luo X; Wang X; Luo Q
Neuropsychopharmacology; 2023 Feb; 48(3):552-559. PubMed ID: 36376466
[TBL] [Abstract][Full Text] [Related]
4. Evidence of Non-Linear Associations between Frustration-Related Prefrontal Cortex Activation and the Normal:Abnormal Spectrum of Irritability in Young Children.
Grabell AS; Li Y; Barker JW; Wakschlag LS; Huppert TJ; Perlman SB
J Abnorm Child Psychol; 2018 Jan; 46(1):137-147. PubMed ID: 28315125
[TBL] [Abstract][Full Text] [Related]
5. Dysregulated but not decreased salience network activity in schizophrenia.
White TP; Gilleen J; Shergill SS
Front Hum Neurosci; 2013; 7():65. PubMed ID: 23471456
[TBL] [Abstract][Full Text] [Related]
6. The relationship between antipsychotic D2 occupancy and change in frontal metabolism and working memory : A dual [(11)C]raclopride and [(18) F]FDG imaging study with aripiprazole.
Kim E; Howes OD; Turkheimer FE; Kim BH; Jeong JM; Kim JW; Lee JS; Jang IJ; Shin SG; Kapur S; Kwon JS
Psychopharmacology (Berl); 2013 May; 227(2):221-9. PubMed ID: 23271192
[TBL] [Abstract][Full Text] [Related]
7. Acute effects of single-dose aripiprazole and haloperidol on resting cerebral blood flow (rCBF) in the human brain.
Handley R; Zelaya FO; Reinders AA; Marques TR; Mehta MA; O'Gorman R; Alsop DC; Taylor H; Johnston A; Williams S; McGuire P; Pariante CM; Kapur S; Dazzan P
Hum Brain Mapp; 2013 Feb; 34(2):272-82. PubMed ID: 22451196
[TBL] [Abstract][Full Text] [Related]
8. Differential brain glucose metabolic patterns in antipsychotic-naïve first-episode schizophrenia with and without auditory verbal hallucinations.
Horga G; Parellada E; Lomeña F; Fernández-Egea E; Mané A; Font M; Falcón C; Konova AB; Pavia J; Ros D; Bernardo M
J Psychiatry Neurosci; 2011 Sep; 36(5):312-21. PubMed ID: 21266125
[TBL] [Abstract][Full Text] [Related]
9. Antipsychotic dose and diminished neural modulation: a multi-site fMRI study.
Abbott C; Juárez M; White T; Gollub RL; Pearlson GD; Bustillo J; Lauriello J; Ho B; Bockholt HJ; Clark VP; Magnotta V; Calhoun VD
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):473-82. PubMed ID: 21185903
[TBL] [Abstract][Full Text] [Related]
10. An fMRI study of visual attention and sensorimotor function before and after antipsychotic treatment in first-episode schizophrenia.
Keedy SK; Rosen C; Khine T; Rajarethinam R; Janicak PG; Sweeney JA
Psychiatry Res; 2009 Apr; 172(1):16-23. PubMed ID: 19243925
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of Dysphagia in acute and community mental health settings.
Regan J; Sowman R; Walsh I
Dysphagia; 2006 Apr; 21(2):95-101. PubMed ID: 16763936
[TBL] [Abstract][Full Text] [Related]
12. Stability of emotional dysfunctions? A long-term fMRI study in first-episode schizophrenia.
Reske M; Kellermann T; Habel U; Jon Shah N; Backes V; von Wilmsdorff M; Stöcker T; Gaebel W; Schneider F
J Psychiatr Res; 2007 Dec; 41(11):918-27. PubMed ID: 17467008
[TBL] [Abstract][Full Text] [Related]
13. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
14. Immediate and delayed effects of risperidone on cerebral metabolism in neuroleptic naïve schizophrenic patients: correlations with symptom change.
Ngan ET; Lane CJ; Ruth TJ; Liddle PF
J Neurol Neurosurg Psychiatry; 2002 Jan; 72(1):106-10. PubMed ID: 11784835
[TBL] [Abstract][Full Text] [Related]
15. Risperidone and related 5HT2/D2 antagonists: a new type of antipsychotic agent?
Megens AA; Kennis LE
Prog Med Chem; 1996; 33():185-232. PubMed ID: 8776944
[No Abstract] [Full Text] [Related]
16. Immediate effects of risperidone on cerebral activity in healthy subjects: a comparison with subjects with first-episode schizophrenia.
Lane CJ; Ngan ET; Yatham LN; Ruth TJ; Liddle PF
J Psychiatry Neurosci; 2004 Jan; 29(1):30-7. PubMed ID: 14719048
[TBL] [Abstract][Full Text] [Related]
17. Anatomical and functional cerebral variables associated with basal symptoms but not risperidone response in minimally treated schizophrenia.
Molina V; Reig S; Pascau J; Sanz J; Sarramea F; Gispert JD; Luque R; Benito C; Palomo T; Desco M
Psychiatry Res; 2003 Nov; 124(3):163-75. PubMed ID: 14623068
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
